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Abstract: Modern human life is impossible without products derived from 
classical, contemporary biotechnology. However, large-scale production of 
biotechnology wares opens a discussion about the economic impact, waste 
management, biosafety, and bioethical issues. Plant molecular farming offers a 
relatively inexpensive option for the yielding of many valuable products and 
demonstrates a number of advantages over classical technologies, but also 
raises the questions of further development perspectives, hazard identification 
and risk assessment. This review is focused on these two questions: opportu-
nities offered and challenges faced by modern plant molecular farming systems. 
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1. INTRODUCTION 
During the last decade, plant molecular farming has become a widely used 
pipeline for the production of large variety of economically important compo-
nents, among them bio-pharmaceuticals, enzymes, polymers, etc. Recently, 
several plant-derived biopharmaceutical proteins reached the late stages of com-
mercial development. These products include antibodies, vaccines, human blood 
products, hormones and growth regulators.1 For such products, plants offer prac-
tical and safety advantages as well as lower production costs compared with tra-
ditional systems based on microbial, animal cells or transgenic animals. With 
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ever-increasing number of products in development, plant molecular farming is 
becoming even more competitive. In this review on the subject, recent techno-
logical developments in molecular farming are considered. An attempt has been 
made to give a broad overview on the exploited production systems and on 
several economic and biosafety issues. 
2. BRIEF HISTORY OF MOLECULAR FARMING 
The idea of producing valuable molecules using plants is as old as the first 
plant transformation. Since then a concept of how and which product can be 
efficiently produced in plants has rapidly evolved and developed. The first suc-
cesses of genetic engineering could be defined as the first examples of molecular 
cloning – among them are human somatostatin, human somatotropin, and human 
insulin. The general idea that plant cells could be transformed was developed in 
early 1974.2 Ten years later, the first successful agrobacterium-mediated plant 
transformation (Fig. 1) was reported by de Block et al.3 At the very beginning, 
this technology was dedicated to the improvement the agricultural characteristics 
of crop plants, such as yield,4 lipid content modification5 and optimization of the 
amino acid composition,6 or to provide agents for plant protection, such as bio-
logical insecticides,7 engineered herbicides resistance8 and pathogen resistance.9 
Since then, progress has been made in several different directions, including 
plant transformation systems and plant production lines. Since the initial com-
mercial and scientific interest was focused on the production of proteins or se-
condary metabolites for internal uses in the transgenic plants, the main efforts 
 
Fig. 1. A concise timetable of the development of molecular biotechnology 
and molecular plant farming. 
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were focused on improving transformation efficiency and broadening the host 
plant range.10 In the latter respect, plant transformation systems were developed 
very rapidly. As a result, a number of agrobacterium-mediated transformation, 
direct gene delivery techniques11 and pollen path12 based systems have been 
deployed in different research or commercial plant genetic modification prog-
rams. Lately, the strategies for stable transformation of plants were more inten-
sively substituted with the transient expression approach, which requires less 
time and allows some difficulties related to plant regeneration and somaclonal 
variations to be avoided. Most recently used transient expression systems are 
based on plant viruses “delivered” into the plant cell by Agrobacterium infiltra-
tion. The last decade of plant farming development can be truly called “a decade 
of plantibodies13,14 and biofuel”.15 The intensive research in the field of biofuels 
and the production of human proteins in plants was initiated in both academic 
and research institutions and private companies. 
3. ADVANTAGES OF THE PLANT MOLECULAR FARMING APPROACH 
Expression of potentially valuable pharmaceuticals in plant-based systems 
has a number of advantages over the traditional biotechnological pipelines. 
Molecular farming provides payoffs with high technological, economical, social, 
and ecological impacts. As shown in Fig. 2, plant molecular farming has a re-
markable potential for saving time and labor requirements and improving produc-
tivity and scalability. One of the important technological positives of this ap-
proach is related to the large variety of production systems available for this pur-
pose. For instance, fully contained or open field systems can be easily imple-
mented with some minor adjustments. The fully contained production pipelines 
do indeed require implementation of bioreactors with properties close to those of 
the microbiological fermenters. Furthermore, some of the contained production 
systems demand sufficient light in order to maintain the main plant functions, 
such as photosynthesis. Light has to be evenly distributed in the fermentation 
vessel, which in many cases is difficult to achieve or greatly increases the pro-
duction costs. Therefore, this type of production is usually restricted to locations 
where the sunlight may be used as an energy source and the design of bioreactors 
is strongly influenced by the technical solutions implemented for algae cultiva-
tion. Alternatively, a genetically modified hairy root plant cultures may be used 
in dark vessels. However, this system is limited mainly to the production of 
secondary metabolites. Hairy roots induction is usually achieved by infecting 
plant tissues with the natural plant pathogen, Agrobacterium rhizogenes that 
causes so-called hairy root disease. The neoplastic roots produced by A. rhizo-
genes infection are characterized by high growth rate and genetic stability. These 
genetically transformed root cultures can produce high levels of secondary meta-
bolites or amounts comparable to that of intact plants. Hairy root cultures promise 
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production of valuable secondary metabolites in many plants. The main cons-
traint for the commercial exploitation of hairy root cultures is their scale-up, as a 
specially designed bioreactor that permits the growth of interconnected tissues 
unevenly distributed throughout the vessel would have to be developed. Since the 
hairy root cultures require a fully contained and controlled environment, the 
maintenance cost become equivalent to or higher than those required for conven-
tional fermentation methods. Another Agrobacterium strain, A. tumefaciens, is 
recognized as applicable for plant molecular farming. A. tumefaciens is a natural 
plant pathogen as is A. rhizogenes but instead of forming hairy roots, it induces 
neoplastic growth of formations called “galls”. Molecular farming employs gene-
tically modified strains of A. tumefaciens. The genetic modification of this bac-
terial strain causes asymptomatic infection, which is coupled with the intro-
duction of an additional gene set, coding the expression of a particular econo-
mically important product. Depending on the implemented experimental proce-
dure, two types of results can be achieved: 1) stable plant transformation and 2) 
transient expression of a particular gene. Both methods differ in many aspects. 
The first method requires usage of a natural tumor-inducing plasmid, split in 
 
Fig. 2. A comparative analysis of molecular plant farming vs. traditional biotechnological 
production by Xu et al.16 (with modifications). 
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binary vector systems, modified in such a way that only the desired part of the 
plasmid is incorporated into the plant genome. A stable transformation results in 
inheritable expression of the whole gene set, which usually confers expression of 
two genes – the gene of interest and a marker gene. The latter enables the posi-
tive or negative selection of the transgenic cells. The stable plant transformation 
also offers an additional opportunity for the translocation of the protein product 
into different cell compartments17 and therefore, modification of the natural plant 
synthetic pathways becomes possible. In this respect, the system allows the pro-
duction of not only recombinant proteins, but also the enhancement of the pro-
duction of different secondary metabolites. Regarding the experimental proce-
dure, stable plant transformation is more time and labor consuming but offers more 
sustainable expression in the next generations. Alternatively, transient expression 
offers a short-term high-level expression of a single gene encoding for the protein 
of interest. In this case, the expression cassette is usually cloned into the full 
length or partial plant virus genome, for instance tobacco mosaic virus, potato 
virus X (reviewed by Wagner et al.18), tobacco rattle virus (TRV),19 etc., con-
taining the gene of interest under control of a viral or other suitable promoter. 
The function of the viral genome in this scenario is to ensure the replication and 
subsequent transcription of its exogenously supplemented section. Depending on 
the employed viral component, a systemic or local gene expression may be 
observed. In most cases, the capacity of transient expression systems is limited to 
the production of recombinant proteins for a short-term period. 
Another very promising alternative for genetic manipulation is the chloro-
plast transformation. It is accepted that the first plastids arose from endosym-
biosis between a photosynthetic bacterium and a non-photosynthetic host20 and 
therefore the chloroplast matrix environment is more bacteria-like, which pro-
vides better protein storage conditions for some proteins. The chloroplast genome 
is semi-autonomous: a large part of the chloroplast proteins are encoded by its 
own genome but, simultaneously, a small part of the genetic information is 
translocated to the nucleus of the plant cell – for example the large subunit of 
Rubisco is encoded by the chloroplast genome but the Rubisco small subunit 
encoding gene is located into to the plant nuclear genome.21 Upon translation in 
the cytosol, the small subunit is subsequently transported into the chloroplasts. 
Since the chloroplast transformation is mediated by homologous recombi-
nation of the transgene with the chloroplast genome, identification of spacer 
regions for integration of transgenes and the regulatory sequences is essential for 
experiment design. As the integration into the chloroplast genome is site-specific, 
the concerns of a position effect, frequently observed in nuclear transgenic 
lines,22 are eliminated. As a result of the lack of transgene silencing, high levels 
of accumulation of transcripts have been reported.23 
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On the other hand, in most angiosperm plant species, plastid genes are ma-
ternally inherited24 and therefore, transgenes in these plastids are not dissemi-
nated by pollen. An important advantage of plastid transformation is the ability to 
accumulate large amounts of foreign protein. Expression levels of up to 46 % of 
the total soluble protein were reported by De Cosa et al. and protein crystal 
formation was demonstrated.25 Until now, chloroplast transformation has been 
implemented for the production of many valuable therapeutic proteins, such as 
Human interferon gamma (HIF-γ), Human somatostatin (hST), vaccines against 
antrax,26 tetanus,27 cholera,28 etc. Chloroplast transformation has also been in-
volved in production of a number of biomaterials such as monellin,29 elastin-
derived polymers,30 etc. 
In most cases, plant molecular farming systems require a certain degree of 
biosafety measures. After appropriate risk assessment, transgenic plants may be 
cultivated under regular field conditions according to the risk management prog-
rams developed for certain crops. In fact, only the cost of plant material process-
sing is additional to the standard farming costs.  
4. BIOSAFETY ISSUES RELATED TO MOLECULAR FARMING IN PLANTS 
Considering that in most cases of molecular farming in plants or plant-de-
rived cell/tissue cultures one is dealing with different degrees of genetically mo-
dified organisms, biosafety is gaining significant importance. The first two ques-
tions that require adequate answers are: 1) what is the hazard, respectively, how 
to identify the hazard and 2) what is the biological risk of implementation of such 
technology. Once the hazard is identified, exposure to the genetically modified 
event has to be determined. The risk is calculated using the formula:  
  Risk = Hazard×Exposure  
Hazard identification requires assessment of the potential gene transfer 
events, which are divided into two main classes: vertical and horizontal gene 
transfer. Vertical gene transfer is the movement of genetic material between at 
least partially sexually compatible plants. In this case, crops for molecular 
farming should be chosen with the minimization of gene flow in mind. This is the 
most prevalent form of transgene pollution and occurs predominantly via the 
dispersal of transgenic pollen, resulting in the formation of hybrid seeds with a 
transgenic male parent.31 Hybrid seeds could also be generated with the trans-
genic plant as the female parent if the transgenic crops were fertilized by wild 
type pollen. In this case, transgene pollution would occur via seed dispersal, 
during growth, harvesting or transport. 
Horizontal gene transfer represents genetic material exchange between sex-
ually incompatible species that may belong to very different taxonomic groups. It is 
common in prokaryotes, resulting in the transfer of plasmid-borne resistance between 
different bacteria species. There are only few examples of natural gene transfer 
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between bacteria and higher eukaryotes. Since agrobacterium represents a special 
case where gene transfer occurs naturally from bacteria to plants, there is a per-
ceived risk for horizontal gene transfer. In most cases, gene transfer from trans-
genic plants to soil bacteria or microorganisms in the digestive systems of herbi-
vores is a subject of concern. The eventually transferred traits could have unpre-
dictable effects on the relationships between different organisms, i.e., render harm-
less bacteria pathogenic or make pathogenic species more difficult to control, etc. 
Numerous potential solutions to the problem of transgene pollution caused 
by either horizontal or vertical gene transfer have already been developed. 
When discussing biosafety issues related to genetically modified plants, it is 
necessary to recognize contamination with GM material during transport as an 
important hazard factor, especially in the case of post-harvest processing of the 
plant material (seeds, foliage, fruits, etc.). The risk of contamination becomes 
significant when genetically modified and conventionally produced plant mate-
rials or products are processed in the same installations or transported in the same 
vehicles. As complete cleaning is not possible in most cases, 0.8 % GM conta-
mination in goods has been accepted as a threshold (this may differ in different 
countries).  
5. CONCLUDING REMARKS 
Research over the past 20 years has significantly increased knowledge in the 
field of molecular biology and especially the understanding of gene expression in 
higher plants, and technological development enabled plant derived cells or tis-
sue to be cultured using different platforms. This has enabled a move from pure 
laboratory studies in model species to the exploration of a variety of different 
plants for the production of recombinant proteins and a number of secondary 
metabolites. Broad ranges of technical, pharmaceutical and industrial proteins 
have been produced in plants, some on a commercial basis. The main efforts 
were focused on overcoming the technical limitations of molecular farming, 
particularly by increasing low yields in some expression systems. However, there 
are several further challenges concerning the issues of environmental impact, 
biosafety and risk assessment, which reflect the release and agricultural-scale 
cultivation of transgenic plants, as well as the safety of the plant-derived products 
themselves.  
ИЗВОД 
МОЛЕКУЛАРНИ АСПЕКТИ ГАЈЕЊА БИЉАКА – МОГУЋНОСТИ И ИЗАЗОВИ 
RUMYANA VALKOVA, ELENA APOSTOLOVA и SAMIR NAIMOV 
University of Plovdiv, Department of Plant Physiology and Molecular Biology, Plovdiv 4000, Bulgaria 
Модеран живот људи је немогуће замислити без производа проистеклих из класи-
чне или модерне биотехнологије. Биотехнолошка производња великих размера отвара 
питања економског значаја, руковања отпадом, биолошке безбедности и биоетике. Га-
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јење биљака на молекуларној основи нуди релативно јефтину могућност производње ве-
ликог броја значајних производа и има одређене предности у односу на класичну про-
изводњу, али повлачи са собом и процену перспективе даљег развоја, идентификацију 
опасности и ризика овакве технологије. У овом ревијском раду описане су могућности и 
изазови примене система модерног молекуларног гајења биљака. 
(Примљено 5. новембра, ревидирано 16. децембра 2012) 
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